Diffuse mixed lymphomas are NCI classified
Diffuse Large B-Cell Lymphoma (DLBCL) is an aggressive Non-
I submit that there is only one reason why any newly diagnosed cancer patient should not get a
Patients with primary cutaneous
Researchers from Weill Cornell Medical College believe they have discovered a new pathway for
For years, researchers have been looking for the right biomarkers to make the most accurate
The most frequently diagnosed subtype of non-Hodgkin's